---
$id: https://graph.org.ai/services/commodity/85444502
$type: Service
source: UNSPSC
code: "85444502"
title: "The diagnosis of cefalosporins and beta-lactam antibiotics"
class: "85444500"
classTitle: "Diagnoses of injuries from adverse effects of drugs in therapeutic use: systemic antibiotics"
family: "85440000"
familyTitle: "Diagnoses of external causes of morbidity and mortality"
segment: "85000000"
segmentTitle: "Healthcare Services"


---

# The diagnosis of cefalosporins and beta-lactam antibiotics

**UNSPSC Code**: 85444502
**Class**: [Diagnoses of injuries from adverse effects of drugs in therapeutic use: systemic antibiotics](Diagnoses of injuries from adverse effects of drugs in therapeutic use systemic antibiotics.mdx)
**Family**: [Diagnoses of external causes of morbidity and mortality](../Diagnoses of external causes of morbidity and mortality.mdx)
**Segment**: [Healthcare Services](../../Healthcare Services.mdx)

In this classification, this covers the group of activities that yields a diagnosis of cefalosporins and other beta-lactam antibiotics. Cefalosporins and other beta-lactam antibiotics is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y40.1.

